J05AE Protease inhibitors, direct acting antivirals
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 28 drugs in this drug class and its subclasses.
- 28 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
-
J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AE01 Saquinavir 1 drug
- J05AE02 Indinavir 2 drugs
- J05AE03 Ritonavir 4 drugs
- J05AE04 Nelfinavir 1 drug
- J05AE05 Amprenavir 2 drugs
- J05AE07 Fosamprenavir 1 drug
- J05AE08 Atazanavir 5 drugs
- J05AE09 Tipranavir 1 drug
- J05AE10 Darunavir 9 drugs
- J05AE30 Nirmatrelvir and ritonavir 2 drugs
-
J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Amprenavir 2 drugs
- Atazanavir (atazanavir sulfate) 5 drugs
- Darunavir 5 drugs
- Darunavir (darunavir ethanolate) 3 drugs
- Darunavir (darunavir propylene glycolate) 1 drug
- Fosamprenavir (fosamprenavir calcium) 1 drug
- Indinavir (indinavir sulfate) 2 drugs
- Nelfinavir (nelfinavir mesylate) 1 drug
- Nirmatrelvir 2 drugs
- Ritonavir 6 drugs
- Saquinavir (saquinavir mesylate) 1 drug
- Tipranavir 1 drug
Drugs in the class and its subclasses
Other classes of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05AP Antivirals for treatment of HCV infections 16 drugs
- J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
- J05AX Other antivirals 13 drugs
Other names of the drug class
- Czech: J05AE Inhibitory proteáz
- English (United Kingdom): J05AE Protease inhibitors, direct acting antivirals
- French: J05AE inhibiteurs de protéase
- German: J05AE Proteasehemmer
- German (Austria): J05AE Proteasehemmer
- Italian: J05AE INIBITORI DELLE PROTEASI
- Polish: J05AE Inhibitory proteazy
- Turkish: J05AE Proteaz inhibitörleri, doğrudan etkili antiviraller
- Portuguese (Brazil): J05AE Inibidores da protease
- German (Switzerland): J05AE Proteasehemmer
- French (Switzerland): J05AE Inhibiteurs de protéase
- Italian (Switzerland): J05AE Inibitori delle proteasi
- Dutch: J05AE Proteaseremmers, direct werkende antivirale middelen
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AE
Ask your doctor or pharmacist for advice.